SCHEMBL22002723

SCHEMBL22002723

CCCCCCCCCCCCC1C(O)CCC1CC(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ ALOX5 P09917 1/20 0.36
▸ TBXA2R P21731 1/20 0.35
▸ PTGFR P43088 1/20 0.35
▸ PTGER2 P43116 1/20 0.35
▸ GBA1 P04062 4/20 0.35
▸ NAAA Q02083 3/20 0.35
▸ GLB1 P16278 1/20 0.35
▸ GBA2 Q9HCG7 1/20 0.35
▸ GUSB P08236 1/20 0.34
▸ DGKA P23743 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22002779 1.00 ALDH1A1 (0.38) ALDH1A1USP2ALOX15TDP1POLB
SCHEMBL19914951 1.00 ALDH1A1 (0.38) ALDH1A1USP2ALOX15TDP1POLB
SCHEMBL16206614 0.99 ALDH1A1 (0.36) ALDH1A1USP2ALOX15TDP1POLB
SCHEMBL15526611 0.93 PRKCA (0.34) ALDH1A1USP2ALOX15TDP1POLB
SCHEMBL16206615 0.89 NAAA (0.37) ALDH1A1USP2L3MBTL1ALOX5TBXA2R
SCHEMBL2793920 0.85 PTGER2 (0.35) POLBALOX5TBXA2RPTGFRPTGER2
SCHEMBL6916806 0.85 PTGER2 (0.35) POLBALOX5TBXA2RPTGFRPTGER2
SCHEMBL15527693 0.84 TSHR (0.33) ALDH1A1ALOX5TBXA2RPTGFRPTGER2
SCHEMBL15527893 0.82 PTGER2 (0.33) ALDH1A1POLBL3MBTL1PTGER2TSHR
SCHEMBL15527745 0.82 PTGER2 (0.39) ALDH1A1POLBL3MBTL1PTGER2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10654788-B2 Method for synthesizing novel compounds derived from 3-hydroxy-cyclopentyl acetic acid L'OREAL (FR) 2020-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10654788-B2 Method for synthesizing novel compounds derived from 3-hydroxy-cyclopentyl acetic acid HSD17B12, FASN, AKR1C3 ALDH1A1 39/4885USP2 2385/4885ALOX15 141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback